Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Automated medical image segmentation using deep learning requires large labelled datasets, presenting barriers for rare cancers like sarcoma. We developed an agentic framework integrating LLM analysis of radiologist reports with nnUNet segmentation for 18F-FDG PET/CT imaging data (N=60, 134 studies), aiming to improve automated tumour segmentation for retrospective data. LLM interpretation was opt...
Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer spanning a biologic continuum from atypical ductal hyperplasia (ADH) to high-grade lesions with variable risk of progression to invasive ductal carcinoma (IDC), yet diagnostic accuracy remains limited when based on morphologic assessment via hematoxylin and eosin (H&E) alone. TRPV4, a mechanosensitive ion channel we previously demonst...
Early cancer detection substantially improves patient survival, yet conventional screening methods are directed at single anatomical sites and inadequ...
To identify clusters of high-cost patients in England based on diagnoses and sociodemographic characteristics to inform targeted population health man...
Cancer remains one of the most significant global health challenges. De-spite advances in treatment, early detection remains a critical concern. The i...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, the disconnect between efficacy in randomized tria...
Computational pathology increasingly relies on foundation models pre-trained on large-scale histopathology datasets, but existing models require subst...
The project aimed to develop a data-driven approach for predicting platelet recovery in cancer treatment–induced thrombocytopenia (CTIT) patients rece...
We present a new method for lung pathology detection in blood plasma, including lung cancer staging. Raman spectroscopy uses inelastically scattered l...
The adoption of artificial intelligence in dermatology promises democratized access to healthcare, but model reliability depends on the quality and co...
Early-onset colorectal cancer (EOCRC) continues to rise, with the steepest increases observed among Hispanic/Latino (H/L) populations, underscoring th...
The incidence of early-onset colorectal cancer (EOCRC; <50 years) is rising rapidly among populations. Although alterations in the RTK-RAS signaling p...
Identification of minimally invasive biomarkers of different stages of cachexia (Ca), and precachexia (PCa) in particular, might help clinicians in tr...
The increasing availability of electronic health records (EHRs) provides opportunities to apply machine learning (ML) methods in support of clinical d...
Colon Cancer (CC) is among the most frequently diagnosed malignancies and a leading cause of cancer-related death worldwide. Five-year survival varies...
FOLR3 serves as an important member of the folate metabolic pathway and plays a crucial role in various malignant tumors. However, the expression patt...
Colorectal cancer (CRC) exhibits marked heterogeneity across age, ancestry, and treatment context, underscored by the rising incidence of early-onset ...
Immunotherapy has improved outcomes in non-small cell lung cancer (NSCLC), but only a subset of patients achieves durable survival benefit. Convention...
Proteome-guided liquid biopsy tests hold immense promise for the future of early cancer detection. Our previous published work has shown strong perfor...
Low-dose computed tomography (LDCT) lung cancer screening has significantly enhanced early detection and patient survival rates in the population at r...